Acnase

Quick links to important sections

Acnase

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Acnase

Acnase: The Foundational Definition and Purpose

Property Description
Active ingredient Benzoyl Peroxide (Dibenzoyl Peroxide)
Form Gel, Cream, Lotion, Cleansing Bar (Topical Application)
Pharmacological class Topical Acne Agent
Common use Management of Acne Vulgaris
Origin Synthetic Compound

Acnase: Definition and Pharmacological Classification

Acnase is a specialized topical dermatological medication used to manage conditions associated with acne, classified broadly as a Topical Acne Agent. Its therapeutic efficacy is derived from the synthetic chemical compound Benzoyl Peroxide (INN: Dibenzoyl Peroxide), which acts directly on the skin's surface. Acnase is historically associated with the Brazilian pharmaceutical market and its manufacturers. Benzoyl Peroxide is used as a treatment for non-inflammatory and inflammatory acne lesions. The medication is recognized as a standard treatment for primary acne symptoms.


Composition and Forms of Benzoyl Peroxide

The core active ingredient in Acnase is Benzoyl Peroxide, which is formulated into various preparations for skin use. The medication is available in several dosage forms, including a drying gel, a moisturizing cream, a liquid lotion, and a cleansing bar, allowing for tolerance and effective delivery across different skin types. Benzoyl Peroxide is chemically stable and suitable for compounding as both a Monotherapy and within a Combination Product alongside other agents like topical retinoids or antibiotics. This means the core compound can be utilized in varied formulations to suit different skin needs and treatment strategies.


General Purpose and Type of Action

The general purpose of Acnase is to help clear acne-related blemishes by combining a clearing action with microbial control. This Topical Acne Agent functions through a dual mechanism principle: it acts as a mild keratolytic agent, promoting the gentle shedding of skin cells to prevent pore blockage, and simultaneously exerts a powerful, non-specific oxidizer effect. Its use is clinically recognized for improving the appearance of blemishes in patients with mild to moderate Acne Vulgaris, representing a typical use scenario across adolescents and adults.

Regulatory References

  1. NIH MedlinePlus on Benzoyl Peroxide

What side effects are possible with Acnase?

Possible Side Effects and Safety Information

This section describes the officially documented adverse reactions and safety characteristics of Acnase (Benzoyl Peroxide) as classified by government regulatory authorities.


Classification of Adverse Reactions

The most common adverse reactions associated with topical Benzoyl Peroxide primarily involve the Skin and Subcutaneous Tissue Disorders system-organ class. These local reactions are typically dose- and concentration-dependent.

Frequency Classification Examples of Officially Documented Adverse Reactions
Very Common (ge 1/10) Skin dryness, erythema (redness), skin peeling (desquamation), burning sensation at application site
Common (ge 1/100 to < 1/10) Pruritus (itching), pain or stinging sensation, irritant contact dermatitis
Uncommon (ge 1/1,000 to < 1/100) Allergic contact dermatitis

Serious Reactions and Safety Constraints

Serious Adverse Reactions are rare but officially documented, including reports of anaphylaxis (a severe, systemic allergic reaction) and facial edema (swelling of the face) classified as Frequency Not Known (post-marketing reports). These serious events fall under the Immune System Disorders category.

Official labeling notes a clear time-related safety pattern: local skin irritation and redness are typically most pronounced during the initial weeks of treatment but tend to decrease in intensity with continued regular use of the medication.

The medication is officially restricted for use in individuals with a known history of hypersensitivity to Benzoyl Peroxide. Safety constraints also advise avoiding contact with sensitive areas such as the eyes, mouth, nostrils, and other mucous membranes due to the risk of severe irritation.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information for Acnase (Topical Benzoyl Peroxide) defines overdose primarily as a localized event resulting from excessive application or misuse of highly concentrated product.

Documented Overdose Manifestations

Element Official Regulatory Statement
Primary Manifestations Excessive peeling (desquamation), severe localized irritation, significant redness (erythema), swelling (edema), and a burning sensation.
Systemic Risk Systemic toxicity is not expected or documented in regulatory profiles due to minimal dermal absorption.

Required Emergency Actions

The most important action upon observing severe localized effects is discontinuation of use. When signs of overdose, such as blistering, excessive swelling, or unmanageable irritation, are present, regulators mandate that the patient seek immediate medical attention.

No specific antidote is known for Benzoyl Peroxide overdose; therefore, the required official management approach is symptomatic and supportive treatment, including the use of emollients to soothe the skin. If accidental ingestion occurs, contact with a poison control center is the required official action.


This profile defines the overdose situation as a non-systemic, localized toxic effect, with the severity of the dermatological symptoms being the official trigger for seeking urgent medical help.

Therapeutic Uses of Acnase

What Acnase Treats: Main Uses and Benefits

Acnase (Benzoyl Peroxide) is commonly used in the management of symptoms associated with mild to moderate acne.

Acnase is considered relevant in the management of both non-inflammatory lesions, such as blackheads and whiteheads, and the more visible, symptomatic inflammatory lesions like papules and pustules. The medication is relevant for easing groups of symptoms that may become more disruptive during flare-ups, which contributes to improved comfort during periods of heightened symptoms. Its use is common in maintenance therapy for conditions involving recurrent or episodic manifestations, and it may support general well-being during symptomatic phases.

“It is relevant in situations where patients experience recurrent acne, and is applied in addressing symptomatic manifestations.”

Quick Fact: Relief for Acne Symptoms

The primary therapeutic benefit relates to supportive symptom management during conditions characterized by periods of heightened symptoms. It supports patients during episodes of heightened discomfort by addressing symptoms related to inflammatory or irritative states and helping manage symptoms that interfere with daily functioning.

Regulatory References

  1. NIH MedlinePlus Drug Information overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Acnase?

Eligibility to use Acnase (Benzoyl Peroxide) is determined by official regulatory labeling, focusing on age, known allergies, and skin condition.


Official Eligibility and Restrictions

Category Regulatory Status (Benzoyl Peroxide)
Allowed Populations Adults and Adolescents ge 12 years for the topical management of acne vulgaris.
Contraindication Known Hypersensitivity (allergy) to Benzoyl Peroxide or any component of the specific product formulation.
Pediatric Use Not Established/Not Recommended for children below 12 years of age as safety and efficacy data are insufficient.
Skin Integrity Prohibited on very sensitive skin, or any skin that is damaged, broken, scraped, or affected by conditions like sunburn or eczema.
Pregnancy/Lactation Generally Acceptable during pregnancy (FDA Category C for monotherapy) and Lactation due to minimal systemic exposure. Application must avoid the chest area during breastfeeding.

The regulatory profile prohibits use based on absolute hypersensitivity and restricts application to areas of intact skin. Use is conditioned on a patient being at least 12 years of age, as the necessary data for younger children is not available in official documentation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Acnase, which contains Benzoyl Peroxide and Sulfur, is primarily defined by the potential for combined local skin reactions rather than systemic drug-drug interactions. Authoritative regulatory documents emphasize caution regarding co-administration with other topical products.

Interaction-Related Restrictions

Classification Constraint / Requirement
Pharmacodynamic Local Effect Use with other topical medicinal products or preparations that induce peeling, desquamation, or irritation requires careful evaluation.
Co-administration Avoid concurrent use of other topical agents on the same affected skin area unless specifically advised by a healthcare professional.

Interacting Product Categories

Official labeling addresses interactions with substances that share similar local effects:

  • Other Topical Acne Agents: Products containing ingredients like tretinoin, tazarotene, or salicylic acid may lead to cumulative irritation or excessive drying when used at the same time as this product.
  • Other Drying Preparations: Topical agents specifically noted to produce a strong drying effect should be used cautiously or avoided due to the potential for compounding dryness and discomfort.

Summary of Regulatory Context

The regulatory documentation classifies potential interactions as clinically significant mainly in the context of topical co-administration. There are no documented pharmacokinetic (CYP enzyme or transporter-mediated) interactions listed for the core ingredients in their topical formulation. The principal regulatory requirement is to prevent the additive effects of local skin irritation by managing the use of other simultaneous topical treatments.

Mechanism of Action

How Acnase Works at the Molecular Level

Acnase exerts its action across three distinct mechanistic domains, engaging key biological targets and pathways to modulate processes within the pilosebaceous unit.


Modulating the Microbial Growth Pathway

Acnase acts as a targeted agent to disrupt essential metabolic and cellular processes within the P. acnes bacterium, thereby initiating or suppressing signaling sequences that limit the proliferation of this microorganism. This engagement with microbial pathways results in the establishment of a lowered bacterial burden within the targeted skin pathways.


Regulating Follicular Cell Differentiation

This mechanism involves modulating the activity of keratinocytes through interaction with defined enzyme or receptor systems that control cell shedding. By modifying early molecular steps, Acnase supports the regulation of processes driven by distinct signaling patterns within the pore lining, modulating keratinocyte differentiation to alter the turnover rate, which reduces excessive cellular adhesion.


Dampening Pro-Inflammatory Cytokine Cascades

Acnase engages mechanisms that regulate inflammatory responses by acting on the cytokine signaling network. It modifies molecular cascades (e.g., NF-κB) responsible for releasing key mediators like IL-6 and TNF-α, suppressing signaling sequences that lead to downstream effects. This limits the impact of excessive mediator activity, which results in the dampening of inflammatory signaling sequences.

Dosage and Administration Information

Acnase, which contains the active ingredient Benzoyl Peroxide, is a medication administered exclusively via the topical route directly to the skin's surface. This product is typically restricted from oral, ophthalmic, or intravaginal use.


Dosing and Frequency Patterns

The standard regimen for topical application is typically characterized by a gradual titration. Treatment most often starts with one application daily to the affected areas. Following this initial period, the frequency may be cautiously increased to two or three times per day as needed or as tolerated by the individual. For leave-on gels, creams, and lotions, a dose described as a thin layer or a pea-sized amount is applied to cover the entire affected region.


Contextual and Population-Specific Usage

For proper administration, the skin must be cleansed thoroughly and dried before applying the product. The application must strictly avoid the eyes, mouth, and mucous membranes.

Regarding specific populations, Acnase products are indicated for use in patients 12 years of age and older for the topical treatment of acne vulgaris. The safety and effectiveness in pediatric patients younger than 12 years of age have not been established. Use over time is generally part of a longer-term treatment plan, with some formulations suggesting reassessment if no clinical improvement is observed after 12 weeks of consistent use.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Acnase


Evidence Base for Mild to Moderate Acne Vulgaris

Research into the main ingredient of Acnase, Benzoyl Peroxide, includes numerous Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews that explore its use in research contexts involving typical acne. These studies were primarily conducted during periods of increased symptom activity in adolescents and adults who had been diagnosed with mild to moderate Acne Vulgaris. Researchers examined outcomes related to physical discomfort and the overall condition by monitoring changes in total acne lesions and using clinician ratings, such as the Investigator's Global Assessment (IGA), to evaluate findings related to skin condition.

The collected data from these trials, which compare the active product against an inactive vehicle (or placebo), describe patterns of outcomes measured during short- to medium-term observation. Findings from systematic evidence reviews help contextualize patient-reported outcomes and how symptoms evolved in the observed populations during the study period.

However, research provides limited insight into long-term outcomes. Long-term outcomes following the typical 12-week trial period are not well characterized by existing randomized evidence. Also, results apply mainly to the populations studied, and evidence quality varies across studies due to differences in the specific concentration (e.g., 2.5% versus 10%) and formulation (gel vs. cream) used.


Evidence for Inflammatory Lesions (Papules and Pustules)

Specific research has been conducted exploring the use of Benzoyl Peroxide in relation to inflammatory lesions like papules and pustules, which are conditions characterized by heightened symptom activity. Studies monitored changes over defined time intervals and included individuals whose conditions involved these more noticeable episodes. Research was conducted during periods of increased symptom activity, and studies examined outcomes linked to inflammatory or irritative states, including the change in counts of papules and pustules. Researchers also explored microbiological outcomes, with findings describing measurements of C. acnes bacteria populations.

Medium-term trials reported measurements describing how inflammatory lesion counts evolved over the study periods. Further studies explored the relationship between product use and microbiological outcomes.

Despite these findings, there is limited information for long-term outcomes; few data sets are available to provide insight into patterns of inflammatory lesion counts in maintenance settings beyond the typical 12-week trial duration. Additionally, findings were mixed when comparing monotherapy to combination products, and specific subgroup findings on the optimal concentration for purely inflammatory outcomes are uncertain.

Key Studies & References

  1. Benzoyl Peroxide - StatPearls (Overview of mechanism, uses, and concentrations)
  2. Label: ACNE TREATMENT - benzoyl peroxide gel (FDA/DailyMed Monograph for OTC formulations)

Frequently Asked Questions (FAQ)

Common questions about Acnase (FAQ)

Q: How quickly do people typically start to notice any effects from Acnase?

A: Clinical study data and official summaries describe that improvement may be noted as early as 4 weeks after consistent application. However, reaching the product's full intended effect may take longer, with outcomes observed across studies generally after 2 to 4 months of continuous use.

Q: What happens if I accidentally miss a dose of Acnase?

A: Official patient instructions generally describe two common approaches. One is applying the missed dose when remembered, and the other is skipping it if it is nearly time for the next scheduled application, in order to return to the regular schedule and avoid excessive application.

Q: Is it true that Acnase can make you sensitive to sunlight?

A: Regulatory documents describe a potential for sun sensitivity or photo-irritation with this product. Because of this, official guidance cautions against unnecessary sun exposure and may mention the use of sun protection and protective clothing during product use.

Q: Are there any specific foods or drinks that should be avoided while using Acnase?

A: Acnase is applied topically to the skin, meaning its action is local. The official interaction profile primarily focuses on other topical skin products, and there are no specific warnings in the primary regulatory documentation concerning interactions with food or non-alcoholic drinks.

Q: Why do some sources say Acnase should not be taken with alcohol?

A: Official guidance advises against the concurrent use of other products that may have drying or irritating effects on the skin. This caution is described in relation to the risk of compounding irritation and dryness, specifically mentioning alcohol-based skincare products for topical co-administration.

Q: Can Acnase be used alongside common over-the-counter pain relievers?

A: Regulatory documents focus on local topical interactions and state there are no documented pharmacokinetic (systemic) drug-drug interactions listed for the core ingredients. This is consistent with the product’s minimal absorption into the bloodstream.

Q: What is the difference between Acnase and Drug X (a similar drug)?

A: Acnase is officially classified as a Topical Acne Agent containing the active ingredient Benzoyl Peroxide. Differences compared to other similar medications, such as those containing salicylic acid or topical retinoids, are based on their specific chemical classifications and distinct pharmacological pathways.

Q: Can people who are pregnant use Acnase?

A: Official regulatory documents generally describe the use of this ingredient during pregnancy as permissible due to the product’s minimal systemic absorption through the skin. For monotherapy, it is often assigned an FDA Pregnancy Category C classification.

Q: What does official guidance say about using Acnase during breastfeeding?

A: Official guidance indicates that use during lactation is generally considered compatible because there is minimal systemic exposure. However, official labeling advises that the application should strictly avoid the chest area to prevent accidental transfer to the infant.

Q: Is Acnase appropriate for children or teenagers?

A: The official product labeling states that Acnase is indicated for use in patients 12 years of age and older. Regulatory documentation notes that the safety and effectiveness for children younger than 12 years of age have not been established in official documents.

Q: Can Acnase be taken on an empty stomach?

A: Acnase is a topical medication that is applied directly to the skin's surface. Since it is not swallowed or taken orally, its application and effectiveness are unrelated to food intake or the state of the stomach.

Q: Is the purpose of Acnase to cure a condition or just to manage symptoms?

A: The official indication, as consistently described in regulatory documents, is the management or treatment of acne vulgaris. Regulatory agencies do not use the term 'cure' in relation to this specific medication.

Q: Is Acnase considered a long-term or short-term treatment?

A: Regulatory texts describe the product's use as generally being part of a longer-term treatment plan for acne management. Some formulations suggest reassessment by a healthcare professional after 12 weeks of consistent use to evaluate progress.

Q: Are there any known issues with Acnase and birth control pills?

A: Regulatory documentation, which details potential drug-drug interactions, does not specifically list an interaction between topically applied Benzoyl Peroxide and oral contraceptives. This finding aligns with the minimal systemic absorption profile of the topical product.

Q: Does Acnase affect your ability to drive or operate machinery?

A: As Acnase is a topical product with minimal absorption into the bloodstream, official regulatory documents do not typically include warnings or cautions concerning effects on cognitive function, driving ability, or the operation of machinery.

Q: Are the side effects of Acnase permanent?

A: The most common local skin reactions, such as irritation, redness, and peeling, are described in official safety information as being most pronounced during the initial weeks of treatment. These effects tend to decrease in intensity with continued regular use, which is consistent with temporary effects.

Q: How does Acnase interact with herbal supplements like St. John's Wort?

A: Regulatory guidance advises caution regarding the use of other topical agents, which would include many herbal or natural remedies, on the same affected skin area. This caution is intended to prevent cumulative irritation, dryness, or peeling effects.

Q: If I have a history of liver problems, is Acnase still an option?

A: Because the product is applied topically and is noted to have minimal systemic absorption into the body, the primary regulatory documentation does not typically list restrictions for individuals with pre-existing liver conditions.

Q: What is the process the body uses to eliminate Acnase?

A: According to official pharmacokinetic data, the Benzoyl Peroxide absorbed through the skin is rapidly and almost entirely converted into Benzoic Acid. This compound is then eliminated from the body primarily in the urine.

Q: Is there a generic version of Acnase available?

A: Yes, regulatory bodies, including the FDA, have approved equivalent generic versions and formulations of products containing the active ingredient Benzoyl Peroxide.

Q: Can Acnase be used by people with kidney issues?

A: Given that Acnase is applied topically and has minimal absorption into the overall body system, the regulatory documentation does not typically list restrictions for individuals with pre-existing kidney conditions.

Q: Is Acnase considered safe by the main regulatory bodies?

A: Regulatory bodies have reviewed products containing Benzoyl Peroxide. The FDA has determined that Benzoyl Peroxide, in concentrations of 2.5% to 10%, is appropriate for topical use in the management of acne.

Q: What is the evidence that Acnase is better than no treatment at all?

A: Official research and systematic reviews detail the results of randomized, placebo-controlled trials. Studies describe that the active product has shown a measurable reduction in both inflammatory and non-inflammatory lesions when compared to the use of an inactive vehicle (or placebo).

Q: Do food or antacids change how much Acnase the body absorbs?

A: Since Acnase is a topical medication, its administration route means that food or antacids taken orally do not affect its absorption or the amount of the drug that acts on the skin.

How should Acnase be stored and disposed of?

How to Store and Dispose of Acnase

Acnase (Benzoyl Peroxide) must be stored according to regulatory labeling to ensure stability and safety.

Storage Requirements

The product must be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F).

Do not freeze and protect the product from excessive heat and direct light. The container must be kept tightly closed and sealed. Store this and all medications out of the sight and reach of children.

Handling and Disposal

Avoid contact with hair and dyed fabrics, as the medicine may cause bleaching. Disposal of unused or expired Acnase must follow local, state, and federal regulations for pharmaceutical waste. The product must not be poured into drains or waterways.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Acnase found in:

A-Z Index: